Celgene CEO to Exit With $40 Million If He Leaves After Bristol Takeover

(Bloomberg) -- Celgene Corp. Chief Executive Officer Mark Alles will collect about $40 million if he leaves the company after his firm is acquired by Bristol-Myers Squibb Co.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.